369 related articles for article (PubMed ID: 24795626)
1. Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors.
Shinohara M; Sato N; Shimamura M; Kurinami H; Hamasaki T; Chatterjee A; Rakugi H; Morishita R
Front Aging Neurosci; 2014; 6():71. PubMed ID: 24795626
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment.
Shah U; Shah A; Patel S; Patel A; Patel M; Solanki N; Patel S; Patel A; Patel V; Patel B
CNS Neurol Disord Drug Targets; 2023; 22(10):1462-1471. PubMed ID: 36200162
[TBL] [Abstract][Full Text] [Related]
3. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
4. Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?
Crum J; Wilson J; Sabbagh M
Alzheimers Res Ther; 2018 Oct; 10(1):104. PubMed ID: 30285877
[TBL] [Abstract][Full Text] [Related]
5. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women.
Szoeke C; Goodwill AM; Gorelik A; Dennerstein L; Caeyenberghs K; Simpson S; Hill E; Campbell S
J Alzheimers Dis; 2019; 68(1):105-114. PubMed ID: 30689578
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.
Tosun D; Demir Z; Veitch DP; Weintraub D; Aisen P; Jack CR; Jagust WJ; Petersen RC; Saykin AJ; Shaw LM; Trojanowski JQ; Weiner MW;
Alzheimers Dement; 2022 Jul; 18(7):1370-1382. PubMed ID: 34647694
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.
Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH
Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of statins in Alzheimer's disease.
Kandiah N; Feldman HH
J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
[TBL] [Abstract][Full Text] [Related]
12. Dual effects of statins on Aβ metabolism: upregulation of the degradation of APP-CTF and Aβ clearance.
Sato N; Shinohara M; Rakugi H; Morishita R
Neurodegener Dis; 2012; 10(1-4):305-8. PubMed ID: 22301944
[TBL] [Abstract][Full Text] [Related]
13. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
Höglund K; Blennow K
CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
[TBL] [Abstract][Full Text] [Related]
14. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.
Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A
Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS).
Liu Z; Shi D; Cai Y; Li A; Lan G; Sun P; Liu L; Zhu Y; Yang J; Zhou Y; Guo L; Zhang L; Deng S; Chen S; Yu X; Chen X; Zhao R; Wang Q; Ran P; Xu L; Zhou L; Sun K; Wang X; Peng Q; Han Y; Guo T
Alzheimers Res Ther; 2024 Apr; 16(1):84. PubMed ID: 38627753
[TBL] [Abstract][Full Text] [Related]
16. AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages.
Volloch V; Olsen BR; Rits S
Ann Integr Mol Med; 2020; 2(1):75-89. PubMed ID: 32201863
[TBL] [Abstract][Full Text] [Related]
17. Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain.
Winer JR; Mander BA; Helfrich RF; Maass A; Harrison TM; Baker SL; Knight RT; Jagust WJ; Walker MP
J Neurosci; 2019 Aug; 39(32):6315-6324. PubMed ID: 31209175
[TBL] [Abstract][Full Text] [Related]
18. Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.
Geifman N; Brinton RD; Kennedy RE; Schneider LS; Butte AJ
Alzheimers Res Ther; 2017 Feb; 9(1):10. PubMed ID: 28212683
[TBL] [Abstract][Full Text] [Related]
19. Statin therapy for Alzheimer's disease: will it work?
Petanceska SS; DeRosa S; Olm V; Diaz N; Sharma A; Thomas-Bryant T; Duff K; Pappolla M; Refolo LM
J Mol Neurosci; 2002; 19(1-2):155-61. PubMed ID: 12212773
[TBL] [Abstract][Full Text] [Related]
20. Midlife Lifestyle Activities Moderate APOE ε4 Effect on
Jeon SY; Byun MS; Yi D; Lee JH; Ko K; Sohn BK; Lee JY; Ryu SH; Lee DW; Shin SA; Kim YK; Kang KM; Sohn CH; Lee DY
Front Aging Neurosci; 2020; 12():42. PubMed ID: 32256335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
